SERPINA3 and early-onset autosomal dominant Alzheimer disease: SERPINA3, which is commonly highly expressed in the brain tissue of Alzheimer’s disease patients, is essentially a serine protease inhibitor that attenuates neuroinflammation and cellular damage by inhibiting the activity of histone G as well as other inflammation-related enzymes [12].